使用小型USP装置进行小体积溶解测试的儿科迷你平板电脑:监管和方法考虑
Stefanie Broocks1, Melanie Gebhardt1, Sandra Klein2
1Department of Pharmacy, Institute of Biopharmaceutics and Pharmaceutical Technology, University of Greifswald, 3 Felix Hausdorff Street, 17489, Greifswald, Germany.
AAPS PharmSciTech
|November 26, 2025
概括
迷你平板电脑 (MTs) 需要专门的溶解测试. 一个小体积的交互持有器装置在评估延长释放 (ER) 迷你平板电脑时,与迷你系统相比,显示出更高的灵敏度.
科学领域:
- 制药技术 制药技术 制药技术
- 药物输送系统 药物输送系统
- 分析化学 分析化学
背景情况:
- 迷你片 (MTs) 是重要的儿科剂量形式,但缺乏标准化的质量控制 (QC) 方法,特别是延长释放 (ER) 配方.
- 现有的质量控制方法可能无法充分评估微型药物输送系统的性能.
研究的目的:
- 评估两个小型溶解装置 (迷你和小体积的反转支架) 用于评估ER MTs.
- 确定这些系统对儿科药物产品的敏感性和歧视力.
主要方法:
- 测试了使用Mini-Paddle (USP 2) 和小体积反转支架 (USP 7) 装置的氨酸和甲 ER MT.
- 从单个和操纵的批次中评估药物释放,以评估方法性能.
主要成果:
- 互换持有人装置为两种药物产品提供了敏感的单个单元测试,检测批量变化.
- 迷你Paddle装置显示了低剂量配方的局限性,掩盖了因单元组合而导致的个体变化.
结论:
- 小体积的互换持有器是ER MTs的QC的一个有前途的工具,提供了卓越的灵敏度.
- 对于MT的监管接受和质量保证,迫切需要标准化,小型化的溶解方法.
相关概念视频
In Vitro Drug Dissolution: Compendial Testing Models I
209
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
209
In Vitro Drug Dissolution: Compendial Testing Models II
224
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
224
In Vitro Drug Dissolution: Alternative Methods
182
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
182
Drug Dissolution: Requirements and Profile Comparison
220
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
220
Factors Affecting Dissolution: Particle Size and Effective Surface Area
1.6K
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
1.6K
In Vitro Drug Release Testing: Overview, Development and Validation
291
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
291


